Home/Filings/4/0001415889-22-013020
4//SEC Filing

RAKIN KEVIN 4

Accession 0001415889-22-013020

CIK 0001708527other

Filed

Dec 26, 7:00 PM ET

Accepted

Dec 27, 6:09 PM ET

Size

20.8 KB

Accession

0001415889-22-013020

Insider Transaction Report

Form 4
Period: 2022-12-22
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-12-22+17,53317,533 total(indirect: See footnote)
    Exercise: $3.80Exp: 2032-12-21Class A Common Stock (17,533 underlying)
HighCape Capital, L.P.
Director10% Owner
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-12-22+17,53317,533 total(indirect: See footnote)
    Exercise: $3.80Exp: 2032-12-21Class A Common Stock (17,533 underlying)
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-12-22+17,53317,533 total(indirect: See footnote)
    Exercise: $3.80Exp: 2032-12-21Class A Common Stock (17,533 underlying)
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-12-22+17,53317,533 total(indirect: See footnote)
    Exercise: $3.80Exp: 2032-12-21Class A Common Stock (17,533 underlying)
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-12-22+17,53317,533 total(indirect: See footnote)
    Exercise: $3.80Exp: 2032-12-21Class A Common Stock (17,533 underlying)
RAKIN KEVIN
Director10% Owner
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-12-22+17,53317,533 total(indirect: See footnote)
    Exercise: $3.80Exp: 2032-12-21Class A Common Stock (17,533 underlying)
Zuga Matt
Director10% Owner
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-12-22+17,53317,533 total(indirect: See footnote)
    Exercise: $3.80Exp: 2032-12-21Class A Common Stock (17,533 underlying)
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-12-22+17,53317,533 total(indirect: See footnote)
    Exercise: $3.80Exp: 2032-12-21Class A Common Stock (17,533 underlying)
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-12-22+17,53317,533 total(indirect: See footnote)
    Exercise: $3.80Exp: 2032-12-21Class A Common Stock (17,533 underlying)
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-12-22+17,53317,533 total(indirect: See footnote)
    Exercise: $3.80Exp: 2032-12-21Class A Common Stock (17,533 underlying)
Footnotes (2)
  • [F1]This option vests in full and shall be fully exercisable on June 20, 2023, subject to Mr. Rakin's continuing in service on the Issuer's board of directors through the vesting date.
  • [F2]Granted to Kevin L. Rakin as non-employee member of the Issuer's board of directors.

Issuer

AZIYO BIOLOGICS, INC.

CIK 0001708527

Entity typeother

Related Parties

1
  • filerCIK 0001184421

Filing Metadata

Form type
4
Filed
Dec 26, 7:00 PM ET
Accepted
Dec 27, 6:09 PM ET
Size
20.8 KB